Hematologic Malignancies Market to Reach USD 128.48 Billion by 2032, Driven by Immunotherapy, CAR-T, and Precision Oncology - Credence Research Inc.
PR Newswire —
The new report "Hematologic Malignancies Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast 2024–2032" has been added to the library of Credence Research Inc. LONDON, March 3, 2026 /PRNewswire/ -- The Hematologic Malignancies Market is projected to grow from USD...